Literature DB >> 25344867

Is there a higher prevalence of human papillomavirus infection in Chinese laryngeal cancer patients? A systematic review and meta-analysis.

Chunlin Zhang1,2, Zeyi Deng3,4, Yuehong Chen5, Mikio Suzuki4, Minqiang Xie6.   

Abstract

Accumulating evidence suggests that persistent human papillomavirus (HPV) infection is closely related to the risk of certain types of head and neck squamous cell carcinoma types, including laryngeal cancer (LC). Some reports indicated a higher HPV prevalence in Chinese LC patients, which remains to be established due to small study sample sizes. The aim of this study was to estimate the HPV infection rate in Chinese LC patients and assess the LC risk conferred by high-risk subtype HPV infection by meta-analysis. We searched MEDLINE, the Embase Database, Chinese National Knowledge Infrastructure, Wanfang Database, and VIP Database for studies published in either English or Chinese up to October 2013, and systematically reviewed 28 original research articles that met the inclusion criteria. Both the HPV infection rate in the LC group (all 28 studies) and the LC risk from high-risk HPV infection (a subgroup of 12 case-control studies) were analyzed by R 3.0 software. Overall HPV, HPV-16/18, and HPV-6/11 infection rates were 32 % (95 % CI 22-44 %), 30 % (95 % CI 24-37 %), and 12 % (95 % CI 9-17 %), respectively. There was a strong association between high-risk HPV-16/18 infection and LC (P < 0.01; OR = 8.07, 95 % CI 5.67-11.48). Our research indicates that there is a higher HPV prevalence in Chinese LC patients compared to LC patients outside of China and that HPV infection significantly increases LC risk.

Entities:  

Keywords:  Chinese population; Human papillomavirus; Laryngeal cancer; Meta-analysis

Mesh:

Year:  2014        PMID: 25344867     DOI: 10.1007/s00405-014-3345-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  29 in total

1.  FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-05-28       Impact factor: 17.586

Review 2.  HPV vaccination in head and neck HPV-related pathologies.

Authors:  Małgorzata Wierzbicka; Agata Józefiak; Joanna Jackowska; Jarosław Szydłowski; Anna Goździcka-Józefiak
Journal:  Otolaryngol Pol       Date:  2014-06-03

3.  HPV and head and neck cancer.

Authors:  X Dufour; A Beby-Defaux; G Agius; J Lacau St Guily
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2011-09-25       Impact factor: 2.080

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

Review 6.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

7.  Human papillomavirus DNA sequences and p53 over-expression in laryngeal squamous cell carcinomas in Northeast China.

Authors:  X L Ma; K Ueno; Z M Pan; S Z Hi; M Ohyama; Y Eizuru
Journal:  J Med Virol       Date:  1998-03       Impact factor: 2.327

Review 8.  Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know.

Authors:  Eric M Genden; Ian M Sambur; John R de Almeida; Marshall Posner; Alessandra Rinaldo; Juan P Rodrigo; Primož Strojan; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-30       Impact factor: 2.503

9.  Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.

Authors:  Stan L Block; Terry Nolan; Carlos Sattler; Eliav Barr; Katherine E D Giacoletti; Colin D Marchant; Xavier Castellsagué; Steven A Rusche; Suzanne Lukac; Janine T Bryan; Paul F Cavanaugh; Keith S Reisinger
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

10.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

View more
  2 in total

1.  Prevalence of HPV genotypes and assessment of their clinical relevance in laryngeal squamous cell carcinoma in a northeastern state of Brazil-a retrospective study.

Authors:  Charlles Brito; Rachel D Cossetti; Diego Agra de Souza; Marcos Catanha; Pablo de Matos Monteiro; Flavia Castello Branco Vidal
Journal:  PeerJ       Date:  2022-07-12       Impact factor: 3.061

2.  Relationship Between p16 Expression and Prognosis in Patients with Oropharyngeal Cancer Undergoing Surgery.

Authors:  Kota Kida; Tomonori Terada; Nobuhiro Uwa; Yoshihiko Omori; Takashi Fujii; Yasuhiko Tomita; Kenzo Tsuzuki; Hiroki Nishikawa; Masafumi Sakagami
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.